×
Entrez Id: 22933
Gene Symbol: SIRT2
SIRT2
0.200
Biomarker
phenotype
RGD
Over-expression of PUMA correlates with the apoptosis of spinal cord cells in rat neuropathic intermittent claudication model.
23658678 2013
×
Entrez Id: 836
Gene Symbol: CASP3
CASP3
0.200
Biomarker
phenotype
RGD
Over-expression of PUMA correlates with the apoptosis of spinal cord cells in rat neuropathic intermittent claudication model.
23658678 2013
×
Entrez Id: 581
Gene Symbol: BAX
BAX
0.200
Biomarker
phenotype
RGD
Over-expression of PUMA correlates with the apoptosis of spinal cord cells in rat neuropathic intermittent claudication model.
23658678 2013
×
Entrez Id: 572
Gene Symbol: BAD
BAD
0.200
Biomarker
phenotype
RGD
Over-expression of PUMA correlates with the apoptosis of spinal cord cells in rat neuropathic intermittent claudication model.
23658678 2013
×
Entrez Id: 4193
Gene Symbol: MDM2
MDM2
0.200
Therapeutic
phenotype
RGD
Over-expression of PUMA correlates with the apoptosis of spinal cord cells in rat neuropathic intermittent claudication model.
23658678 2013
×
Entrez Id: 578
Gene Symbol: BAK1
BAK1
0.200
Biomarker
phenotype
RGD
Over-expression of PUMA correlates with the apoptosis of spinal cord cells in rat neuropathic intermittent claudication model.
23658678 2013
×
Entrez Id: 27113
Gene Symbol: BBC3
BBC3
0.200
Biomarker
phenotype
RGD
Over-expression of PUMA correlates with the apoptosis of spinal cord cells in rat neuropathic intermittent claudication model.
23658678 2013
×
Entrez Id: 2034
Gene Symbol: EPAS1
EPAS1
0.200
Therapeutic
phenotype
RGD
Silencing of int6 gene restores function of the ischaemic hindlimb in a rat model of peripheral arterial disease.
21771896 2011
×
Entrez Id: 3646
Gene Symbol: EIF3E
EIF3E
0.200
Therapeutic
phenotype
RGD
Next, we explored the therapeutic effects of int6 siRNA injected into the adductor magnus muscle on IC .
21771896 2011
×
Entrez Id: 4000
Gene Symbol: LMNA
LMNA
0.100
Biomarker
phenotype
HPO
ZMPSTE24
0.100
Biomarker
phenotype
HPO
×
Entrez Id: 64131
Gene Symbol: XYLT1
XYLT1
0.100
Biomarker
phenotype
HPO
×
Entrez Id: 368
Gene Symbol: ABCC6
ABCC6
0.100
GeneticVariation
phenotype
CLINVAR
×
Entrez Id: 368
Gene Symbol: ABCC6
ABCC6
0.100
CausalMutation
phenotype
CLINVAR
×
Entrez Id: 64132
Gene Symbol: XYLT2
XYLT2
0.100
Biomarker
phenotype
HPO
×
Entrez Id: 54790
Gene Symbol: TET2
TET2
0.100
Biomarker
phenotype
HPO
×
Entrez Id: 189
Gene Symbol: AGXT
AGXT
0.100
Biomarker
phenotype
HPO
×
Entrez Id: 4352
Gene Symbol: MPL
MPL
0.100
Biomarker
phenotype
HPO
×
Entrez Id: 3717
Gene Symbol: JAK2
JAK2
0.100
Biomarker
phenotype
HPO
×
Entrez Id: 368
Gene Symbol: ABCC6
ABCC6
0.100
Biomarker
phenotype
HPO
×
Entrez Id: 7422
Gene Symbol: VEGFA
VEGFA
0.030
AlteredExpression
phenotype
BEFREE
Plasma concentrations of tumor necrosis factor α (TNF-α), interleukin-6 (IL-6), interleukin-1ß (IL-1ß), hepatocyte growth factor, and vascular endothelial growth factor were higher in IC subjects at baseline, and TNF-α, IL-6, and IL-18 increased after walking as did IL-6 and IL-1ß in control subjects.
30684623 2019
×
Entrez Id: 7422
Gene Symbol: VEGFA
VEGFA
0.030
Biomarker
phenotype
BEFREE
In this study we examined the effects of VEGF GT on patients having received VEGF-A gene transfer for the treatment of symptomatic (that is, claudication or critical lower limb ischemia) peripheral arterial occlusive disease.
21776026 2012
×
Entrez Id: 7422
Gene Symbol: VEGFA
VEGFA
0.030
Biomarker
phenotype
BEFREE
Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication .
14504183 2003
×
Entrez Id: 23569
Gene Symbol: PADI4
PADI4
0.020
Biomarker
phenotype
BEFREE
Methods and Results A total of 1272 patients with PAD and new or worsening claudication were enrolled at 16 vascular specialty clinics (2011-2015, PORTRAIT (Patient-Centered Outcomes Related to Treatment Practices in Peripheral Arterial Disease: Investigating Trajectories) registry).
30371269 2018
×
Entrez Id: 1401
Gene Symbol: CRP
CRP
0.020
Biomarker
phenotype
BEFREE
Presence of temporal headache (p = 0.003), jaw claudication (p = 0.001), abnormal artery exploration (p = 0.023), elevated erythrocyte sedimentation rate (p = 0.035), CRP (p = 0.018) and platelets (p = 0.042), were significantly associated with GCA.
29680850 2018